stii_1's Profile
Displaying 51-62 of 62 result(s).
Go to page:
Recent Articles
- Bionano Genomics Unveils Important Findings on T-ALL in Kids
- Exciting Launch of Brayden Preserve by LGI Homes in North Carolina
- Fly-E Group Expands to South America with New Store Launch
- Replimune's Innovative Progress in Immunotherapy Financial Review
- Natalia Premovic Joins Playboy's Board for Future Growth
- Prime Medicine's Financial Results Showcase Strong Growth and Progress
- GCM Grosvenor Reports Strong Q2 2025 Earnings Growth and Insights
- Daré Bioscience Unveils Financial Insights and Updates Soon
- Enviri Corporation Showcases Commitment at Investor Events
- Ascentage Pharma Plans 2025 Mid-Year Results Release and Update
- Belite Bio's Direct Offering: What Investors Should Know
- Insightful Position Updates from Rathbones Group Plc
- Kinetic Seas Unveils Skilliks: A Game-Changer for AI Software Projects
- Insights on Apax Global Alpha Limited's Disclosure Position
- Rathbones Group Plc Reveals Financial Interests in Assura Plc
- Breadboard Welcomes Nemanja Jokanovic as New Sales VP
- Victoria's Secret & Co. Announces Upcoming Earnings Call Webcast
- Trump's New Tariffs: Economic Strategy or Potential Downfall?
- Genie Energy Reports Strong Q2 2025 Growth and Challenges
- Transforming Clarence Square: A Green Haven in Downtown
- Cars.com: Impressive Growth Report for Q2 2025
- Exciting Enhancements to Clarence Square Park: A Green Oasis
- Nova Ltd. Delivers Record Financial Results in Second Quarter
- Join AI Prop's Exciting Global Raffle for Dubai Experience!
- TEGNA Inc. Delivers Q2 2025 Earnings and Strategic Insights
- WhiteHorse Finance Reports Q2 Earnings and Confident Outlook
- Daxor's FDA-Approved Blood Volume Analyzer Revolutionizes Care
- Sabre Corporation's Strong Q2 2025 Earnings Release Overview
- FleishmanHillard Elevates Leadership for Global Corporate Affairs
- Insights from 3 E Network CEO Dr. Yang on Digital Assets
- Fidelity National Financial Declares Latest Dividend Payment
- Collegium Pharmaceutical: Second Quarter 2025 Financial Highlights
- Suburban Propane Partners Reveals Challenges and Insights
- Cassava Sciences Welcomes Dr. Hulihan as New CMO for Growth
- MACOM Technology Solutions Achieves Remarkable Q3 Financial Growth
- F&G Annuities & Life Announces Quarterly Dividend Payments
- Knight Therapeutics Enhances Growth and Financial Position
- Innovative AI+ Solutions Drive Technological Growth and Collaboration
- illumin Holdings Reports Impressive Q2 2025 Financial Growth
- Jacobs Secures Contract for Rail Upgrades at Major Port Facility
- Palvella Therapeutics Discusses Q2 2025 Financial Outcomes
- Knight Therapeutics' Q2 2025 Financial Success and Updates
- EverBank's Bold Move with New Subordinated Notes Offering
- Chris Layden Steps in as Kelly Services’ New CEO
- Portland General Electric Launches 475 MW Battery Systems
- Cassava Sciences Welcomes Dr. Joseph Hulihan as CMO
- Y-mAbs Therapeutics Prepares to Share Q2 2025 Insights
- Assessing India's Economic Risk Amid US Tariff Challenges
- Kelly Appoints Chris Layden as New CEO to Drive Growth
- illumin Holdings Inc. Reports Impressive Q2 Performance
